Overview
Infant formula choice is shaped by two traps: stage commercialization (stage 1/2/3/4 is often marketing; regulations classify by infant / follow-on / young child formula) and key ingredient metrics (protein, fat, carbs, DHA/ARA, iron must align with local standards and age). Formula must match the baby's age and any allergies or digestive needs; special medical formulas require medical advice.
Theory anchor: T1 Matching Theorem — the right formula matches the baby's age and health and meets regulatory and registration requirements, not the most expensive or "imported" option.
Step 1 → Need clarification (M1)
Scenario analysis
| Scenario | Key considerations |
|---|---|
| 0–3 months | Infant formula (stage 1); breast milk first; when not possible, choose compliant stage 1 |
| 6–2 months | Follow-on formula (stage 2), with complementary foods |
| 12+ months | Young child formula (stage 3), optional; milk + balanced diet possible |
| Allergy / special needs | Special medical purpose formula; must follow medical advice |
Example need list
- Must-have: product has formula registration, stage matches age, ingredients within local standards
- Nice-to-have: clear DHA/ARA, iron, key nutrients on label
- Bonus: reliable channel, price sustainable long-term
Step 2 → Allocate cognitive budget (T2)
Infant formula is high-stakes, low reversibility (Decision Reversibility is low). Per T2 Cognitive Budget, invest substantial cognitive budget and prioritize pediatrician or dietitian input.
Step 3 → Multi-dimensional evaluation (M2)
Apply M2 Multi-Dimensional Evaluation.
| Dimension | What to assess | Evidence sources |
|---|---|---|
| Compliance and registration | Formula registration number, standard compliance | Official sources, regulator |
| Stage and age | Stage 1/2/3 vs age alignment | Package and local standards |
| Key ingredient metrics | Protein, fat, carbs, DHA, ARA, iron, vitamin D | Nutrition label |
| Special formulas | Lactose-free, partially hydrolyzed; medical indication | Product info, doctor |
Step 4 → Bias and persuasion hazards
- Authority bias: "Doctor recommended" may be brand partnership; special medical formulas must be doctor-directed.
- Stage commercialization: More stages do not mean more science; standards define infant / follow-on / young child (ref. T4.2 Corollary).
- Halo effect: Import does not equal safer; check local registration and legitimate channel.
Step 5 → Decision and validation (M5)
Apply M5 Decision Validation. Checklist: registration verified? Stage matches age? Special formula doctor-confirmed? Post-purchase: observe acceptance, stools, growth (Need consistency).